Resultado de búsqueda
Feng Zhang (China, 1981) es un neurocientífico especializado en optogenética y biología de síntesis, que investiga sobre herramientas de edición del ADN y su aplicación al tratamiento futuro de enfermedades psiquiátricas.
Feng Zhang (Chinese: 张锋; pinyin: Zhāng Fēng; born October 22, 1981) is a Chinese–American biochemist. Zhang currently holds the James and Patricia Poitras Professorship in Neuroscience at the McGovern Institute for Brain Research and in the departments of Brain and Cognitive Sciences and Biological Engineering at the ...
Feng Zhang is a core institute member of the Broad Institute of MIT and Harvard, a professor at MIT, and a molecular biologist who pioneered the development of genome editing tools for studying the brain. He has won many awards, including the Canada Gairdner International Award, the Tang Prize, and the Blavatnik National Award for Young Scientists, and is an elected member of the National Academy of Sciences and the American Academy of Arts and Sciences.
Feng Zhang. HHMI / Massachusetts Institute of Technology / Broad Institute of MIT and Harvard. Verified email at mit.edu - Homepage. neuroscience microbiology optogenetics genome engineering. ... ES Boyden, F Zhang, E Bamberg, G Nagel, K Deisseroth. Nature neuroscience 8 (9), 1263-1268, 2005. 5768: 2005:
Feng Zhang is a molecular biologist who developed optogenetics and CRISPR-Cas systems for genome engineering. He is a professor at MIT, a core member of the Broad Institute, and a Howard Hughes Medical Investigator.
Feng Zhang is a professor and investigator at MIT and the Broad Institute, where he develops CRISPR tools for genome editing and disease research. He also studies brain disorders such as autism and Alzheimer's, and is a founder of several biotech companies.
28 de jun. de 2023 · Feng Zhang, a neuroscientist at MIT and the Broad Institute, has discovered the first RNA-guided DNA-cutting enzyme in eukaryotes, Fanzor, which can target and edit the human genome. The study shows that Fanzor proteins use RNA as a guide to cut DNA more precisely than CRISPR/Cas systems. The team also found that Fanzor can be reprogrammed to edit human cells with efficiency and safety.
